Login / Signup

Cystic fibrosis in Iceland and the high prevalence of the N1303K variant.

Helga ElidottirSelma R BjarnadottirOlafur BaldurssonBrynja Jonsdottir
Published in: Pediatric pulmonology (2024)
Even though Iceland has a relatively low prevalence of CF, it holds the highest known prevalence of the N1303K variant in Europe. Access to necessary treatment is satisfactory, but improvements are advisable for some aspects of the routine assessments by best practice guidelines.
Keyphrases
  • cystic fibrosis
  • risk factors
  • clinical practice
  • pseudomonas aeruginosa
  • primary care
  • healthcare
  • combination therapy
  • quality improvement